Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients

Authors

Institutions

Publication Details

Journal
mSystems
Published
2026-03-23
DOI
https://doi.org/10.1128/msystems.00774-25
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients

Xiaoqiong Lv, Liesheng Lu, Bin Yang, Wei Wu et al.
mSystems
Gut microbiota and health
article

Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients

Xiaoqiong Lv, Liesheng Lu, Bin Yang, Wei Wu, Di Zhao, Lu Wang, Anqi Yu, Junhui Gao, Qiyi Chen, Yue Xu, Ning Li, Man Lu, Yunkun Liu, Xinjun Wang
article en

Abstract

No abstract available for this paper.
mSystems
Tongji University (CN), Center for Digestive and Liver Diseases (US), Suzhou Municipal Hospital (CN), Shanghai Tenth People's Hospital (CN), Shanghai Drug Administration (CN), Shanghai Micro Electronics Equipment (China) (CN)
Good health and well-being
Openalex Percentile: Top 12%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.